- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Fatty Liver in United Kingdom
Total 4334 results
-
Medical College of WisconsinRecruiting
-
Gilead SciencesCompletedNonalcoholic Steatohepatitis (NASH)United States
-
National Cancer Institute (NCI)RecruitingHepatocellular Carcinoma | Nonalcoholic SteatohepatitisUnited States
-
Joel LavineRaptor Pharmaceuticals Corp.Completed
-
89bio, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Gilead SciencesCompletedNonalcoholic SteatohepatitisUnited States, France
-
Genentech, Inc.TerminatedNon-alcoholic SteatohepatitisBelgium, United States, Spain, Puerto Rico, France
-
National Center for Complementary and Integrative...National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedHepatitis C | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Madrigal Pharmaceuticals, Inc.RecruitingNon-Alcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Madrigal Pharmaceuticals, Inc.CompletedNon-Alcoholic Fatty Liver DiseaseUnited States, Puerto Rico
-
Gilead SciencesTerminatedNonalcoholic SteatohepatitisUnited States, Spain, Hong Kong, Canada, Belgium, Australia, Taiwan, India, Japan, Korea, Republic of, Singapore, United Kingdom, Israel, Puerto Rico, France, New Zealand, Germany, Austria, Italy, Mexico, Poland, Switzerland
-
Merck Sharp & Dohme LLCTerminatedNonalcoholic SteatohepatitisKorea, Republic of, United States, Argentina, Australia, Canada, Chile, China, Colombia, France, Germany, Greece, Hong Kong, Israel, Italy, Japan, Malaysia, Mexico, New Zealand, Puerto Rico, Russian Federation, Spain, Sweden, Taiwan, ...
-
Cascade Pharmaceuticals, IncLaboratory Corporation of AmericaCompletedNonalcoholic Steatohepatitis (NASH)United States
-
Ohio State UniversityCompletedMetabolic Syndrome | Non-alcoholic Fatty LiverUnited States
-
Tobira Therapeutics, Inc.CompletedNonalcoholic SteatohepatitisBelgium, Spain, Hong Kong, United States, France, Germany, Australia, United Kingdom, Poland, Italy
-
GenfitPremier Research Group plc; NaturalphaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Belgium, France, Germany, Italy, Netherlands, Romania, Spain, United Kingdom
-
Columbia UniversityUniversity of California, BerkeleyRecruitingInsulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Akero Therapeutics, IncActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Fatty liver FoundationCompletedFatty Liver | NAFLD | NASH - Nonalcoholic Steatohepatitis | Cirrhosis, LiverUnited States
-
Novartis PharmaceuticalsAllerganCompletedNon-alcoholic Steatohepatitis (NASH)United States, Belgium, Spain, Canada, Argentina, Israel, Germany, France, Italy, Turkey, Singapore, Russian Federation, United Kingdom, Czechia, Egypt, India, Latvia
-
PerspectumRecruitingLiver Diseases | Cirrhosis | Primary Sclerosing Cholangitis | Autoimmune Hepatitis | Hemochromatosis | Non-Alcoholic Fatty Liver Disease | Non-Alcoholic Steatohepatitis | Primary Biliary Cirrhosis | Viral HepatitisNetherlands, United Kingdom
-
VA Office of Research and DevelopmentCompletedNonalcoholic SteatohepatitisUnited States
-
University of California, San DiegoRecruitingLiver DiseaseUnited States
-
University of MichiganNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)CompletedNonalcoholic Steatohepatitis | Lipodystrophy | Fatty Liver Disease, NonalcoholicUnited States
-
Redx Pharma PlcSimbec ResearchCompletedLiver Diseases | Fibrosis | Kidney Diseases | Inflammation | Idiopathic Pulmonary Fibrosis | Non-alcoholic SteatohepatitisUnited Kingdom
-
NGM Biopharmaceuticals, IncNGM Biopharmaceuticals Australia Pty LtdCompletedNonalcoholic Steatohepatitis (NASH)United States, Australia, Puerto Rico
-
Massachusetts General HospitalNational Institutes of Health (NIH)WithdrawnNon-alcoholic Fatty Liver DiseaseUnited States
-
Akero Therapeutics, IncCompletedNASH - Nonalcoholic SteatohepatitisUnited States, Puerto Rico
-
Poxel SACompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
Brigham and Women's HospitalBoston Scientific Corporation; American Society for Gastrointestinal EndoscopyRecruitingObesity | Non-alcoholic Fatty Liver Disease (NAFLD) | Liver Function | Non-alcoholic Steatohepatitis (NASH) | Liver Fibroses | Endoscopic Ultrasound | Endoscopic Sleeve GastroplastyUnited States
-
Natalie TorokActive, not recruitingNASH - Nonalcoholic SteatohepatitisUnited States
-
United Arab Emirates UniversityTawam HospitalCompletedCompensated Cirrhosis | Non-alcoholic Fatty Liver | Esophageal VaricesUnited Arab Emirates
-
Inventiva PharmaCompletedNon-Alcoholic Steatohepatitis (NASH)United States, Spain, United Kingdom, France, Belgium, Austria, Switzerland, Australia, Germany, Slovenia, Bulgaria, Canada, Czechia, Italy, Mauritius, Poland
-
Zydus Therapeutics Inc.RecruitingNon-alcoholic Fatty Liver Disease in Women With PCOSUnited States, Mexico
-
Columbia UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Albert...RecruitingObesity | Insulin Resistance | Prediabetic State | Hyperinsulinemia | Non-Alcoholic Fatty Liver DiseaseUnited States
-
HepQuant, LLCCompletedHepatitis C, Chronic | Non-Alcoholic Fatty Liver DiseaseUnited States
-
University of Massachusetts, WorcesterCompletedInsulin Resistance | Morbid Obesity | Non-Alcoholic Fatty Liver DiseaseUnited States
-
Terns, Inc.CompletedNASH - Nonalcoholic SteatohepatitisUnited States
-
HighTide Biopharma Pty LtdCompletedDigestive System Diseases | NAFLD | Nonalcoholic Fatty Liver Disease | Nonalcoholic Steatohepatitis | Type 2 Diabetes Mellitus (T2DM) | Fatty Liver, NonalcoholicUnited States
-
VA Office of Research and DevelopmentRecruitingNonalcoholic Steatohepatitis | Liver FibrosisUnited States
-
CelgeneTerminatedLiver Cirrhosis | Non-alcoholic Fatty Liver DiseaseUnited States, Spain, Australia, Korea, Republic of, Canada, Germany, France, Japan, United Kingdom, Poland
-
Augusta UniversityNational Heart, Lung, and Blood Institute (NHLBI)CompletedNon-alcoholic Fatty Liver Disease | Overweight and ObesityUnited States
-
Terns, Inc.Completed
-
Gilead SciencesTerminatedLiver Fibrosis Due to NASHUnited States, Spain, France, Canada, Germany, Italy, Puerto Rico, United Kingdom, Belgium
-
Akcea TherapeuticsIonis Pharmaceuticals, Inc.CompletedDiabetes Mellitus, Type 2 | NAFLD | Hypertriglyceridemia | Fatty Liver, NonalcoholicUnited States, Canada
-
The University of Texas Medical Branch, GalvestonTerminatedType II Diabetes | Nonalcoholic Fatty LiverUnited States
-
Galectin Therapeutics Inc.CompletedNon-Alcoholic Steatohepatitis (NASH)United States
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Completed
-
Cirius Therapeutics, Inc.Chiltern International Inc.CompletedNon-alcoholic Fatty Liver Disease | NASH - Nonalcoholic Steatohepatitis | Non-alcoholic SteatohepatitisUnited States
-
Tobira Therapeutics, Inc.TerminatedNonalcoholic SteatohepatitisUnited States, Spain, Australia, Belgium, Israel, Canada, Puerto Rico, Italy, Germany, France, New Zealand, Taiwan, Poland, United Kingdom, Brazil, Austria, Singapore, Portugal, Chile, Greece, Hong Kong, Hungary, Latvia, Mexico, Norway, R... and more